Company / SG&A per Share
MBX Biosciences, Inc. SG&A per Share History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.01
FY2024
5-year range
$1.01 / $6.65
FY2023-FY2024
Trend
-84.8%
vs FY2023
Sector context
#120 of 210
Health Care
What the data says
At $1.01, MBX Biosciences, Inc.'s sg&a per share ranks #91 of 210 in the Health Care sector.
Based on SEC 10-K filings.
1.01 in FY2024.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#91 of 210 in Health CareTop 43% of 210This company $1.01 Sector average $40.75
▼
-97.5% below sector average
Key checks
Key Insights
- In FY2024, sg&a per share decreased 84.8% year-over-year.
- Ranks #120 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 9.64 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.01 | -84.8% |
| FY2023 | $6.65 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026